GREEN CROSS WellBeing Corporation
GREEN CROSS WellBeing Corporation provides personalized nutrition injections in South Korea. The company offers health supplements and food; prescription drugs; and aesthetics, as well as nutritional injections, including vitamins and antioxidants. GREEN CROSS WellBeing Corporation was founded in 2004 and is headquartered in Seoul, South Korea.
GREEN CROSS WellBeing Corporation (234690) - Net Assets
Latest net assets as of September 2025: ₩111.99 Billion KRW
Based on the latest financial reports, GREEN CROSS WellBeing Corporation (234690) has net assets worth ₩111.99 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩225.86 Billion) and total liabilities (₩113.87 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩111.99 Billion |
| % of Total Assets | 49.58% |
| Annual Growth Rate | 22.32% |
| 5-Year Change | 26.33% |
| 10-Year Change | N/A |
| Growth Volatility | 59.79 |
GREEN CROSS WellBeing Corporation - Net Assets Trend (2016–2024)
This chart illustrates how GREEN CROSS WellBeing Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for GREEN CROSS WellBeing Corporation (2016–2024)
The table below shows the annual net assets of GREEN CROSS WellBeing Corporation from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩104.95 Billion | +4.55% |
| 2023-12-31 | ₩100.39 Billion | +4.39% |
| 2022-12-31 | ₩96.16 Billion | +8.91% |
| 2021-12-31 | ₩88.30 Billion | +6.28% |
| 2020-12-31 | ₩83.08 Billion | -0.11% |
| 2019-12-31 | ₩83.17 Billion | +188.33% |
| 2018-12-31 | ₩28.84 Billion | +16.15% |
| 2017-12-31 | ₩24.84 Billion | +18.60% |
| 2016-12-31 | ₩20.94 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to GREEN CROSS WellBeing Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 457.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩41.37 Billion | 39.42% |
| Common Stock | ₩8.88 Billion | 8.46% |
| Other Components | ₩54.71 Billion | 52.13% |
| Total Equity | ₩104.95 Billion | 100.00% |
GREEN CROSS WellBeing Corporation Competitors by Market Cap
The table below lists competitors of GREEN CROSS WellBeing Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hafnia Ltd
OL:HAFNI
|
$52.04 Million |
|
Sarawak Plantation Bhd
KLSE:5135
|
$52.04 Million |
|
Tekcore Co. Ltd
TWO:3339
|
$52.05 Million |
|
Tamil Nadu Newsprint & Papers Limited
NSE:TNPL
|
$52.06 Million |
|
Khai Hoan Land Group JSC
VN:KHG
|
$52.03 Million |
|
Yantai North Andre Juice Company Limited
PINK:YNAJF
|
$52.02 Million |
|
Cps Technologies
NASDAQ:CPSH
|
$52.01 Million |
|
INVALDA INVL AB EO-29
F:WTK
|
$52.01 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GREEN CROSS WellBeing Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 100,386,713,920 to 104,952,958,740, a change of 4,566,244,820 (4.5%).
- Net income of 7,069,229,850 contributed positively to equity growth.
- Dividend payments of 1,775,227,600 reduced retained earnings.
- Share repurchases of 65,986,260 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩7.07 Billion | +6.74% |
| Dividends Paid | ₩1.78 Billion | -1.69% |
| Share Repurchases | ₩65.99 Million | -0.06% |
| Other Changes | ₩-661.77 Million | -0.63% |
| Total Change | ₩- | 4.55% |
Book Value vs Market Value Analysis
This analysis compares GREEN CROSS WellBeing Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.54x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.72x to 1.54x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1590.70 | ₩9100.00 | x |
| 2017-12-31 | ₩1886.63 | ₩9100.00 | x |
| 2018-12-31 | ₩2191.23 | ₩9100.00 | x |
| 2019-12-31 | ₩4684.95 | ₩9100.00 | x |
| 2020-12-31 | ₩4679.80 | ₩9100.00 | x |
| 2021-12-31 | ₩4973.85 | ₩9100.00 | x |
| 2022-12-31 | ₩5417.01 | ₩9100.00 | x |
| 2023-12-31 | ₩5654.86 | ₩9100.00 | x |
| 2024-12-31 | ₩5914.45 | ₩9100.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GREEN CROSS WellBeing Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.74%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.28%
- • Asset Turnover: 0.83x
- • Equity Multiplier: 1.54x
- Recent ROE (6.74%) is below the historical average (10.04%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 16.11% | 9.20% | 1.29x | 1.35x | ₩1.28 Billion |
| 2017 | 16.53% | 9.11% | 1.37x | 1.32x | ₩1.62 Billion |
| 2018 | 19.68% | 10.54% | 1.38x | 1.35x | ₩2.79 Billion |
| 2019 | 6.85% | 8.51% | 0.63x | 1.28x | ₩-2.62 Billion |
| 2020 | 1.84% | 2.02% | 0.66x | 1.38x | ₩-6.78 Billion |
| 2021 | 7.59% | 7.37% | 0.65x | 1.57x | ₩-2.13 Billion |
| 2022 | 8.32% | 7.29% | 0.73x | 1.56x | ₩-1.62 Billion |
| 2023 | 6.72% | 5.60% | 0.77x | 1.56x | ₩-3.29 Billion |
| 2024 | 6.74% | 5.28% | 0.83x | 1.54x | ₩-3.43 Billion |
Industry Comparison
This section compares GREEN CROSS WellBeing Corporation's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $209,689,906,881
- Average return on equity (ROE) among peers: -10.47%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GREEN CROSS WellBeing Corporation (234690) | ₩111.99 Billion | 16.11% | 1.02x | $52.03 Million |
| ORIENTBIO Inc. (002630) | $67.35 Billion | -2.60% | 1.21x | $28.10 Million |
| Green Cross (005250) | $282.15 Billion | 18.83% | 0.53x | $228.88 Million |
| Green Cross Holdings Preference Shares (005257) | $1.44 Trillion | 3.01% | 0.78x | $410.72 Million |
| Pharmicell (005690) | $9.90 Billion | -119.73% | 2.00x | $438.14 Million |
| GeneOne Life Science Inc (011000) | $39.74 Billion | 0.00% | 0.49x | $53.78 Million |
| HLB Co. Ltd (028300) | $77.24 Billion | -21.40% | 1.44x | $4.11 Billion |
| Daesung Microbiological Labs. Co. Ltd (036480) | $25.09 Billion | 18.13% | 0.29x | $14.92 Million |
| Seoulin Bioscience Co.Ltd (038070) | $51.49 Billion | 4.00% | 0.38x | $27.72 Million |
| Hyundai Bioscience Co. Ltd (048410) | $39.30 Billion | 0.00% | 0.56x | $899.28 Million |
| iNtRON Biotechnology Inc (048530) | $64.96 Billion | -4.91% | 0.37x | $83.99 Million |